Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Fierce Biotech
CBER Director Vinay Prasad to depart FDA—again
Prasad has drawn increased criticism throughout his tenure, especially from the rare disease community.
Darren Incorvaia
Mar 6, 2026 5:30pm
Regulatory tracker: Daiichi, AZ's Enhertu wins US priority review
Mar 9, 2026 2:10pm
Uniting for patients: Navigating, accessing, and affording care
Brought to you by
Patient Advocate Foundation
Spruce hooks a commercial chief to prep for rare disease launch
Mar 9, 2026 1:15pm
Novo and Hims & Hers team up to sell branded GLP-1s, ending feud
Mar 9, 2026 11:55am
FDA expands label for BMS' Sotyktu to treat psoriatic arthritis
Mar 9, 2026 11:16am
More News
‘SNL’ pokes fun at mysteries of Amgen’s Otezla for psoriasis
Mar 9, 2026 11:05am
Novo's Indiana plant claims another victim in Incyte's PD-1
Mar 9, 2026 10:45am
Safety signals prompt Ipsen to withdraw cancer med Tazverik
Mar 9, 2026 10:07am
Lonza shakes off capsule business in $3B deal with Lone Star
Mar 6, 2026 4:00pm